Mirae Asset Global Investments
ABVX icon

Mirae Asset Global Investments’s Abivax ABVX Stock Holding History

Mirae Asset Global Investments’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
+2,872
New +$325K ﹤0.01% 1027
2026
Q1 		– Sell
-2,869
Closed -$387K – 1571
2025
Q4 		$387K Buy
+2,869
New +$313K ﹤0.01% 1040

Other funds holding ABVX

TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirae Asset Global Investments's ABVX Position: Q2 2026 in Review

Mirae Asset Global Investments opened a new position in Abivax (ABVX) in Q2 2026: 2,872 shares worth $383K. The stake represents ﹤0.01% of the portfolio and ranks #1027 among its holdings. This is a return to the name: Mirae Asset Global Investments previously reported a position in ABVX as recently as Q4 2025.

Mirae Asset Global Investments first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $387K in Q4 2025. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Mirae Asset Global Investments held 2,872 shares of Abivax worth $383K as of Q2 2026.
  • Abivax was a new Mirae Asset Global Investments position in Q2 2026.
  • Abivax made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1027 holding.
  • Mirae Asset Global Investments first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Mirae Asset Global Investments's Abivax position peaked at $387K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.